PMC:7594251 / 62265-62428 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T454","span":{"begin":80,"end":81},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"easurements [294].\nThe drug design approach based on diffusion NMR is basically a screening technique used to differentiate the binding ligands (drug) from non-bin"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T77748","span":{"begin":23,"end":27},"obj":"Chemical"},{"id":"T85611","span":{"begin":136,"end":143},"obj":"Chemical"},{"id":"T16775","span":{"begin":145,"end":149},"obj":"Chemical"}],"attributes":[{"id":"A12644","pred":"chebi_id","subj":"T77748","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A95467","pred":"chebi_id","subj":"T85611","obj":"http://purl.obolibrary.org/obo/CHEBI_52214"},{"id":"A18397","pred":"chebi_id","subj":"T16775","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"easurements [294].\nThe drug design approach based on diffusion NMR is basically a screening technique used to differentiate the binding ligands (drug) from non-bin"}